These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25325219)

  • 41. Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: findings from the Get With The Guideline-Heart Failure Registry.
    Hsich EM; Grau-Sepulveda MV; Hernandez AF; Eapen ZJ; Xian Y; Schwamm LH; Bhatt DL; Fonarow GC
    Am Heart J; 2013 Dec; 166(6):1063-1071.e3. PubMed ID: 24268222
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
    Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
    Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The clinical value of B-type natriuretic peptide in the diagnosis of left heart failure].
    Zhao XY; Yang YJ; Zhang J; Dang AM; Ni XH; Huang J; Kang S; Ma WH; Zhao DY
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(17):1165-9. PubMed ID: 16796855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relation of left ventricular ejection fraction and clinical features or co-morbidities to outcomes among patients hospitalized for acute heart failure syndromes.
    Kajimoto K; Sato N; Takano T;
    Am J Cardiol; 2015 Feb; 115(3):334-40. PubMed ID: 25476557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. No effect of group-based aerobic interval training on N-terminal pro- B-type natriuretic peptide levels in patients with chronic heart failure.
    Nilsson BB; Westheim A; Risberg MA; Arnesen H; Seljeflot I
    Scand Cardiovasc J; 2010 Aug; 44(4):223-9. PubMed ID: 20636229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Natriuretic Peptide and Clinical Evaluation in the Diagnosis of Heart Failure Hemodynamic Profile: Comparison with Tissue Doppler Echocardiography.
    Almeida Junior GLG; Clausell N; Garcia MI; Esporcatte R; Rangel FOD; Rocha RM; Beck-da-Silva L; Silva FBD; Gorgulho PCC; Xavier SS
    Arq Bras Cardiol; 2018 Mar; 110(3):270-277. PubMed ID: 29694552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effects of cardiac rehabilitation on the physical capacity of individuals with heart failure].
    Holmgeirsdottir KE; Jonsson BG; Aspelund T; Gudmundsson G; Gudlaugsson J
    Laeknabladid; 2019 Nov; 105(11):491-497. PubMed ID: 31663512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of clinical features and outcomes of patients hospitalized with heart failure and normal ejection fraction (> or =55%) versus those with mildly reduced (40% to 55%) and moderately to severely reduced (<40%) fractions.
    Sweitzer NK; Lopatin M; Yancy CW; Mills RM; Stevenson LW
    Am J Cardiol; 2008 Apr; 101(8):1151-6. PubMed ID: 18394450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biochemical diagnosis of impaired left ventricular ejection fraction--comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP).
    Mueller T; Gegenhuber A; Poelz W; Haltmayer M
    Clin Chem Lab Med; 2004 Feb; 42(2):159-63. PubMed ID: 15061354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.
    Richards AM; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton C; Turner J; Crozier IG; Yandle TG
    Circulation; 2003 Jun; 107(22):2786-92. PubMed ID: 12771003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heart failure with preserved left ventricular ejection fraction in patients with acute myocardial infarction.
    Antonelli L; Katz M; Bacal F; Makdisse MR; Correa AG; Pereira C; Franken M; Fava AN; Serrano Junior CV; Pesaro AE
    Arq Bras Cardiol; 2015 Aug; 105(2):145-50. PubMed ID: 26039659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brain natriuretic peptide is a good predictor for outcome in cardiac surgery.
    Elíasdóttir SB; Klemenzson G; Torfason B; Valsson F
    Acta Anaesthesiol Scand; 2008 Feb; 52(2):182-7. PubMed ID: 17949462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
    Yan RT; White M; Yan AT; Yusuf S; Rouleau JL; Maggioni AP; Hall C; Latini R; Afzal R; Floras J; Masson S; McKelvie RS;
    Am J Cardiol; 2005 Sep; 96(5):698-704. PubMed ID: 16125499
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Electrical myostimulation: improvement of quality of life, oxygen uptake and left ventricular function in chronic heart failure].
    van Buuren F; Mellwig KP; Fründ A; Bogunovic N; Oldenburg O; Kottmann T; Wagner O; Dahm JB; Horstkotte D; Fritzsche D
    Rehabilitation (Stuttg); 2014 Oct; 53(5):321-6. PubMed ID: 24363218
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patients with left ventricular ejection fraction greater than 58 % have fewer incidences of future acute decompensated heart failure admission and all-cause mortality.
    Goto T; Wakami K; Fukuta H; Fujita H; Tani T; Ohte N
    Heart Vessels; 2016 May; 31(5):734-43. PubMed ID: 25771802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The differences in the relationship between diastolic dysfunction, selected biomarkers and collagen turn-over in heart failure patients with preserved and reduced ejection fraction.
    Michalski B; Trzciński P; Kupczyńska K; Miśkowiec D; Pęczek Ł; Nawrot B; Lipiec P; Kasprzak JD
    Cardiol J; 2017; 24(1):35-42. PubMed ID: 27748500
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Opposite predictive value of pulse pressure and aortic pulse wave velocity on heart failure with reduced left ventricular ejection fraction: insights from an Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) substudy.
    Regnault V; Lagrange J; Pizard A; Safar ME; Fay R; Pitt B; Challande P; Rossignol P; Zannad F; Lacolley P
    Hypertension; 2014 Jan; 63(1):105-11. PubMed ID: 24126172
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of clinical parameters and cardiac magnetic resonance imaging as predictors of outcome in pediatric myocarditis.
    Sachdeva S; Song X; Dham N; Heath DM; DeBiasi RL
    Am J Cardiol; 2015 Feb; 115(4):499-504. PubMed ID: 25554534
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.
    Amorim S; Rodrigues J; Campelo M; Moura B; Martins E; Macedo F; Silva-Cardoso J; Maciel MJ
    Int J Cardiovasc Imaging; 2017 May; 33(5):605-613. PubMed ID: 28013418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.